title: [Molecular diagnosis of methicillin-resistent Staphylococcus aureus: Methods and efficacy].
abstract: Methicillin-resistant Staphylococcus aureus (MRSA) isolates are a serious public health problem whose ever-increasing rate is commensurate with the pressure it is exerting on the healthcare system. At present, more than 20% of clinical S. aureus isolates in German hospitals are methicillin-resistant, in Austria less than 10%. Strategies from low-prevalence countries show that this development is not necessarily inevitable. In the Scandinavian countries and the Netherlands, thanks to a rigorous prevention programme, MRSA prevalence has been kept at an acceptably low level (< 1-3%). Central to these search-and-destroy control strategies is an admission screening using several MRSA swabs taken from mucocutaneous colonisation sites of high-risk patients (MRSA surveillance). It has also been reported that the speed with which MRSA carriage is detected has an important role, as it is a key component of any effective strategy to prevent the pathogen from spreading. Since MRSA culturing involves a 2-3 day delay before the final results are available, rapid detection techniques (commonly referred to as MRSA rapid tests) using polymerase chain reaction (PCR) methods and, most recently, rapid culturing methods have been developed. The implementation of rapid tests reduces the time of detection of MRSA carriers from 48-72 to 2-5 h. Clinical evaluation data have shown that MRSA can thus be detected with very high sensitivity. Specificity, however, is sometimes impaired due to false-positive PCR signals occurring in mixed flora specimens. In order to rule out false-positive PCR results, a culture screen must always be carried out simultaneously. The data provide preliminary evidence that a PCR assay can reduce nosocomial MRSA transmission in high-risk patients or high-risk areas, whereas an approach that screens all patients admitted to the hospital is probably not effective. Information concerning the cost effectiveness of rapid MRSA tests is still sparse and thus the issue remains debated.
authors.affiliation: Zentrum für Krankenhaushygiene und Infektionskontrolle, Paracelsus Medizinische Privatuniversität Salzburg, Müllner Hauptstrasse 48, 5020, Salzburg, Österreich. m.hell@salk.at.
authors.forename: M
authors.initials: M
authors.lastname: Hell
authors.affiliation: Universitätsklinik für Dermatologie, Paracelsus Medizinische, Privatuniversität Salzburg, Salzburg, Österreich.
authors.forename: J W
authors.initials: JW
authors.lastname: Bauer
authors.affiliation: Universitätsklinik für Dermatologie, Paracelsus Medizinische, Privatuniversität Salzburg, Salzburg, Österreich.
authors.forename: M
authors.initials: M
authors.lastname: Laimer
mesh_terms: D019317:Evidence-Based Medicine; D006801:Humans; D055624:Methicillin-Resistant Staphylococcus aureus / Q000235:genetics* / Q000302:isolation & purification*; D025202:Molecular Diagnostic Techniques / Q000379:methods*; D016133:Polymerase Chain Reaction / Q000379:methods*; D013207:Staphylococcal Skin Infections / Q000175:diagnosis* / Q000382:microbiology*
keywords: Direct detection; Hospitals; Polymerase chain reaction; Rapid test; Screening